These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1619410)

  • 1. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.
    Miller DH; Thompson AJ; Morrissey SP; MacManus DG; Moore SG; Kendall BE; Moseley IF; McDonald WI
    J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):450-3. PubMed ID: 1619410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
    Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J
    Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.
    Barkhof F; Hommes OR; Scheltens P; Valk J
    Neurology; 1991 Aug; 41(8):1219-22. PubMed ID: 1866009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study.
    Oliveri RL; Valentino P; Russo C; Sibilia G; Aguglia U; Bono F; Fera F; Gambardella A; Zappia M; Pardatscher K; Quattrone A
    Neurology; 1998 Jun; 50(6):1833-6. PubMed ID: 9633736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions.
    Burnham JA; Wright RR; Dreisbach J; Murray RS
    Neurology; 1991 Sep; 41(9):1349-54. PubMed ID: 1891079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosis.
    Gasperini C; Pozzilli C; Bastianello S; Koudriavtseva T; Galgani S; Millefiorini E; Paolillo A; Horsfield MA; Bozzao L; Fieschi C
    Neurology; 1998 Feb; 50(2):403-6. PubMed ID: 9484362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
    Liu S; Liu X; Chen S; Xiao Y; Zhuang W
    PLoS One; 2017; 12(11):e0188644. PubMed ID: 29176905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.
    Richert ND; Ostuni JL; Bash CN; Leist TP; McFarland HF; Frank JA
    Mult Scler; 2001 Feb; 7(1):49-58. PubMed ID: 11321194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
    Martinelli V; Rocca MA; Annovazzi P; Pulizzi A; Rodegher M; Martinelli Boneschi F; Scotti R; Falini A; Sormani MP; Comi G; Filippi M
    Neurology; 2009 Dec; 73(22):1842-8. PubMed ID: 19949030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis.
    Sellebjerg F; Jensen CV; Larsson HB; Frederiksen JL
    Mult Scler; 2003 Feb; 9(1):102-7. PubMed ID: 12617276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis.
    Frequin ST; Barkhof F; Lamers KJ; Hommes OR
    J Neuroimmunol; 1992 Oct; 40(2-3):265-72. PubMed ID: 1430156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.
    Barkhof F; Tas MW; Frequin ST; Scheltens P; Hommes OR; Nauta JJ; Valk J
    Neuroradiology; 1994 Jul; 36(5):382-7. PubMed ID: 7936181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patients.
    Gasperini C; Pozzilli C; Bastianello S; Koudriavtseva T; Colleluori A; Millefiorini E; Thompson AJ; Horsfield MA; Galgani S; Bozzao L; Fieschi C
    Acta Neurol Scand; 1997 Apr; 95(4):201-7. PubMed ID: 9150809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
    Fox RJ; Fisher E; Tkach J; Lee JC; Cohen JA; Rudick RA
    Mult Scler; 2005 Apr; 11(2):140-5. PubMed ID: 15794385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis.
    Ozkan S; Uzuner N; Kutlu C; Ozbabalik D; Ozdemir G
    J Clin Neurosci; 2006 Feb; 13(2):214-7. PubMed ID: 16503485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.
    Nos C; Sastre-Garriga J; Borràs C; Río J; Tintoré M; Montalban X
    Mult Scler; 2004 Aug; 10(4):413-6. PubMed ID: 15327039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies.
    Giantzi V; Karapanayiotides T; Lagoudaki R; Poulatsidou KN; Lourbopoulos A; Daniilidis M; Taskos N; Milonas I; Grigoriadis N
    Eur Neurol; 2016; 75(1-2):82-8. PubMed ID: 26867030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses.
    Grau-López L; Teniente-Serra A; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Martínez-Cáceres EM; Ramo-Tello C
    Mult Scler; 2015 Apr; 21(5):646-50. PubMed ID: 25145693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short-term high-dose intravenous methylprednisolone therapy].
    Ohashi T
    Nihon Rinsho; 2014 Nov; 72(11):1995-8. PubMed ID: 25518383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.